中文 | English
Return
Total: 6125 , 1/613
Show Home Prev Next End page: GO
Author:( Shu WANG)

1.Anti-thyroid drugs—first choice for Graves' disease

Shu WANG

Chinese Journal of Practical Internal Medicine 2003;0(01):-

2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry

Shuling WANG ; Shu WANG

China Pharmacy 2005;0(16):-

4.Structure features of reactive oxygen species and NADPH oxidases and their roles in cardiomyocyte proliferation and death

Miao LI ; Shu WANG

Chinese Journal of Tissue Engineering Research 2006;10(45):220-224

5.CSI:New Factor for Marketing Competition of Pharmaceutical Enterprises

Shu WANG ; Wenzhan YANG

China Pharmacy 1991;0(01):-

6.Thinking About the Packaging of Pharmaceutical Products and the Safety of Drug Use

Wenzhan YANG ; Shu WANG

China Pharmacy 1991;0(06):-

7.Effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction

Shu CHEN ; Zongshe WANG

Chinese Journal of Biochemical Pharmaceutics 2015;(11):158-160

8.Roles of PKC in LPS-induced NF-?B activation of macrophages in rats

Shu LI ; Zhengqing WANG ;

Journal of Third Military Medical University 2003;0(19):-

9.Treatment of Lumbar Disc Herniation with Intervertbral Disc Version Operation

Shu HUANG ; Weigang WANG

International Journal of Traditional Chinese Medicine 2009;31(3):209-211

10.Endovascular repair for retrograde type A aortic dissection with an entry tear in the descending aorta

Chang SHU ; Tun WANG

Chinese Journal of General Surgery 2013;28(12):911-914

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6125 , 1/613 Show Home Prev Next End page: GO